−1.50SEK
−134.15 MSEK
35.75 MSEK
38.61 M
About SENZIME AB
Sector
Industry
CEO
Philip Axel Wilhelm Siberg
Website
Headquarters
Uppsala
Founded
1999
ISIN
SE0002478776
FIGI
BBG000QG5XB5
Senzime AB engages in the development of enzyme-based biosensor technology for medical and biochemical processes and industries. It manufactures products for automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patient's neuromuscular function perioperatively and in the intensive care medicine setting. The company also distributes bioreactor systems for the pharmaceutical industry. Senzime was founded by Thomas Ambjorn Carlsson in 1999 and is headquartered in Uppsala, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SEZI is 5.96 SEK — it has decreased by 1.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange SENZIME AB stocks are traded under the ticker SEZI.
SENZIME AB is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
SEZI stock is 4.48% volatile and has beta coefficient of −1.38. Check out the list of the most volatile stocks — is SENZIME AB there?
SEZI earnings for the last quarter are −0.30 SEK per share, whereas the estimation was −0.30 SEK resulting in a 0% surprise. The estimated earnings for the next quarter are −0.30 SEK per share. See more details about SENZIME AB earnings.
SENZIME AB revenue for the last quarter amounts to 9.20 M SEK despite the estimated figure of 10.80 M SEK. In the next quarter revenue is expected to reach 12.80 M SEK.
Yes, you can track SENZIME AB financials in yearly and quarterly reports right on TradingView.
SEZI stock has fallen by 5.55% compared to the previous week, the month change is a 7.45% fall, over the last year SENZIME AB has showed a 10.58% increase.
SEZI net income for the last quarter is −38.81 M SEK, while the quarter before that showed −30.17 M SEK of net income which accounts for −28.61% change. Track more SENZIME AB financial stats to get the full picture.
Today SENZIME AB has the market capitalization of 609.44 M, it has increased by 3.00% over the last week.
No, SEZI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SEZI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SENZIME AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SENZIME AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SENZIME AB stock shows the sell signal. See more of SENZIME AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SENZIME AB EBITDA is −116.28 M SEK, and current EBITDA margin is −325.21%. See more stats in SENZIME AB financial statements.